Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05324956 |
Other study ID # |
2021/348 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
April 2022 |
Est. completion date |
June 2022 |
Study information
Verified date |
April 2022 |
Source |
Izmir Bakircay University |
Contact |
Öykünur Cansu |
Phone |
+902324930000 |
Email |
6009121[@]bakircay.edu.tr |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
If the bone mineral density of a patient with a diagnosis of osteopenia falls further, he
develops osteoporosis.Menopause causes many changes in women's bodies in the form of
vasomotor, sleep disorders, fatigue, aches and pains, altered cognitive functions, as well as
genitourinary problems such as vaginal dryness, irritation, recurrent urinary tract
infections. In the long term, inevitable changes occur in the musculoskeletal system.
Osteoporosis, sarcopenia, postural dysfunction, regression in gait cycle, Loss of balance
control and instability and increased risk of falling are the changes reported during this
period. These mentioned effects negatively affect the quality of life of women. The aim of
this study is to investigate the relationship of bone mineral density with respiratory
functions and exercise capacity in postmenopausal women.The second aim is to compare the
respiratory functions and exercise capacities of postmenopausal women with osteopenia and
osteoporosis.
Description:
The 1993 Consensus Development Conference paper defined osteoporosis as ''a disease
characterized by low bone mass and microarchitectural deterioration of bone tissue, leading
to increased bone fragility and consequent increased risk of fracture.In 1994, the World
Health Organization (WHO) established criteria for measuring bone mineral density (BMD) that
allowed the diagnosis of osteoporosis before fractures. This practical definition is based on
the main (known) risk factor: reduced bone strength or density and people at high risk but
without fractures.Premenopausal women have a low rate of osteoporosis; however, the
prevalence increases with age due to progressive bone loss.Bone densitometry is an
established method for evaluating osteoporosis. Various different methods have been developed
in the last 25 years. DEXA is recommended and FDA approved for BMD measurement; It is
precise, noninvasive, has low radiation exposure and takes 10 minutes to administer.
Osteoporosis can have a significant impact on patients' daily lives. Vertebral deformity
causes loss of spinal mobility, and patients with osteoporosis have difficulty standing,
bending over, getting up from a chair, walking, carrying objects, dressing, fixing hair,
bathing, moving in bed, using the toilet, and descending to the floor. Compared with women
without existing vertebral deformities, women with extensive deformities have higher crude
mortality and hospitalization rates overall.Osteoporosis deprives older women of many of
their social roles. Failure to fulfill roles such as cooking, housework, work, and intimacy
can be devastating, leading to frustration and embarrassment. Interpersonal relationships can
be deeply affected by the effects of osteoporosis, straining family ties and destroying
extra-familial relationships, leading to social isolation. Therefore, treatment options
should be well evaluated because affected individuals should focus not only on bone
remodeling, but also on ways in which negative outcomes such as pain, depression and loss of
self-esteem can be improved. Considering all these situations, we asked the question whether
there is any relationship between bone mineral density and respiratory functions and exercise
capacity. In order to evaluate these parameters, we decided to examine the patient's detailed
demographic information, posture evaluation according to the New York Posture Scale, 6-minute
walking test result, and Pulmonary Function Test result.